The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197.
 
Garth Andrew Nicholas
No Relationships to Disclose
 
John R. Goffin
No Relationships to Disclose
 
Scott Andrew Laurie
No Relationships to Disclose
 
Andrew George Robinson
No Relationships to Disclose
 
Glenwood D. Goss
Honoraria - AstraZeneca
Research Funding - AstraZeneca
 
M. Neil Reaume
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Janssen; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Novartis
 
Mihaela Mates
No Relationships to Disclose
 
Paul Wheatley-Price
Honoraria - AstraZeneca
 
Peter Michael Ellis
Honoraria - Boehringer Ingelheim; Lilly; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Roche
Other Relationship - Celgene
 
Rosalyn A. Juergens
Consulting or Advisory Role - AstraZeneca
 
Anna T. Tomiak
No Relationships to Disclose
 
Richard William Gregg
No Relationships to Disclose
 
Barbara L. Melosky
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Heather Ritter
No Relationships to Disclose
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
 
Penelope Ann Bradbury
No Relationships to Disclose